News

In line with the opportunities created by the PACTE law and the INSERM 2025 Strategic Plan, both designed to foster technology transfer and collaborative research, the Centre d’Immunophénomique (CIPHE), a service unit of INSERM, CNRS, and Aix-Marseille University, and Janvier Labs, an industrial leader in preclinical rodent models, have joined forces to create a new spin-off company: JC Discovery (Janvier Ciphe Discovery).

The GENISIF-DS21 project (Genetics of Peripheral and Neuro-Inflammation in Down Syndrome) has been selected under the ANR AAPG 2025 call!

The LEVISORT project, led by the Immunomics team at CIPHE, has been selected for funding under the 2025 Research Call of Région Sud, with co-funding from AMIDEX.

CIPHE is proud to announce its participation in the RD-factory program, a voluntary initiative led by the Czech Centre for Phenogenomics (CCP) under the leadership of Dr. Radislav Sedláček. This collaborative program is dedicated to addressing rare genetic diseases by uniting leading research centers, patient organizations, and foundations.

CIPHE (Inserm – CNRS – AMU) is proud to actively participate in the VIROCRIB consortium, awarded under the 2024 PEPR Emerging Infectious Diseases – France 2030 initiative. This involvement reflects CIPHE’s commitment to addressing future health crises through cutting-edge research.

The Centre for Immunophenomics (CIPHE) – Inserm US012, CNRS UAR3367, AMU – is proud to play a central role in the European PRIMTECH 3R and INFRAPLUS projects, launched in May 2025. These initiatives, funded by the European Union under HORIZON-RIA and supported by INFRAFRONTIER, the European reference infrastructure for human disease modeling, aim to advance innovative preclinical research strategies.

CIPHE (Inserm – CNRS – AMU) is pleased to announce the renewal of its ISO 9001 certification, highlighting the continued commitment of its teams to rigorous and recognized quality standards. Certified continuously since 2016, CIPHE strengthens its position as a leading Resource, Service, and Research Center for mouse models in biomedical research.

Since 2024, CIPHE has been actively integrating Corporate Social Responsibility (CSR) into its operations, embedding sustainable, inclusive, and ethical practices across all aspects of its research mission.